Operating
Roivant Sciences·Cash Flow Statement·40 metrics
Breakdown
| Metric | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 |
|---|---|---|---|---|---|---|---|---|
| Increase (Decrease) In Litigation Settlement Receivables | $0 | $0 | $0 | $0 | $192.6M | $192.6M | $192.6M | $192.6M |
| Net cash from operating activities | -$192.8M | -$266.8M | -$207.3M | -$172.6M | -$204.4M | -$185.7M | -$196.5M | -$163.8M |
| Stock-based compensation | $50.2M | $71.7M | $83.7M | $83.5M | $82.2M | $81.8M | $105M | $77.2M |
| Change in accrued liabilities | -$37.6M | — | -$3M | — | -$25M | — | — | $63.2M |
| Change in income taxes payable/receivable | -$2.5M | -$2.5M | -$2.5M | -$2.5M | $21.3M | $21.3M | $21.3M | $21.3M |
| Change in other current assets | $16.3M | — | $41.7M | — | -$128K | $4.4M | $2.7M | -$18.5M |
| Increase (Decrease) in Other Current Assets | $16.3M | — | $41.7M | — | -$128K | $4.4M | $2.7M | -$18.5M |
| Change in accounts payable | -$25.3M | — | — | -$165K | -$11.7M | $3M | -$4M | $16.2M |
| Accounts payable | -$25.3M | — | — | -$165K | -$11.7M | $3M | -$4M | $16.2M |
| Lease impairment charges | — | — | — | $0 | $3.9M | $3.9M | $3.9M | $3.9M |
| Non-cash operating lease expense | $1.6M | $1.6M | $1.7M | $2M | $1.9M | $1.9M | $2.5M | $1.9M |
| Operating lease right-of-use asset amortization | $1.6M | $1.6M | $1.7M | $2M | $1.9M | $1.9M | $2.5M | $1.9M |
| Change in other assets | $2.2M | $2.2M | $2.2M | $2.2M | $1.9M | $1.9M | $1.9M | $1.9M |
| Depreciation and amortization | $4.9M | $4.8M | $2.9M | $1.4M | $1.1M | $921K | $691K | $638K |
| Change in operating lease liabilities | -$1.8M | -$1.6M | -$2M | -$241K | -$478K | -$846K | -$786K | -$275K |
| Operating lease liabilities | -$1.8M | -$1.6M | -$2M | -$241K | -$478K | -$846K | -$786K | -$275K |
| Change in other liabilities | $193.3K | $193.3K | $193.3K | $193.3K | -$252K | -$252K | -$252K | -$252K |
| Other non-cash income (expense) | -$5.6M | $17.9M | -$11.9M | -$4.2M | -$11.1M | -$6M | — | — |
| Amortization of Investment Discount and Premium | $0 | $25M | $29.3M | $15.7M | $11.1M | $9.8M | $8.7M | — |
| Accretion (amortization) of discounts and premiums on investments | $0 | $25M | $29.3M | $15.7M | $11.1M | $9.8M | $8.7M | — |
| Other working capital changes | -$12.3M | $20.5M | $6.4M | -$18.4M | $71K | $3.2M | -$8.3M | — |
| Net gains (losses) on investments | $15.2M | $48.4M | -$21.3M | $12.9M | -$19.1M | $128.5M | $21.6M | — |
| Accretion (Amortization) of Investment Discounts and Premiums | $0 | $25M | $29.3M | $15.7M | $11.1M | $9.8M | $8.7M | — |
| Other Non-Cash Income (Expense) | -$5.6M | $17.9M | -$11.9M | -$4.2M | -$11.1M | -$6M | — | — |
| Loss on extinguishment of debt | -$2.2M | -$2.2M | -$2.2M | -$2.2M | — | — | — | $0 |
| Other Non-cash Income (Expense) | -$5.6M | $17.9M | -$11.9M | -$4.2M | -$11.1M | -$6M | — | — |
| Other Non-cash Income (Expense) | -$5.6M | $17.9M | -$11.9M | -$4.2M | -$11.1M | -$6M | — | — |
| Net income | $95.3M | -$279.9M | $118.1M | -$252.4M | -$223.4M | -$166M | -$313.7M | — |
| Other non-cash income (expense) | -$5.6M | $17.9M | -$11.9M | -$4.2M | -$11.1M | -$6M | — | — |
| Accretion (Amortization) of Discounts and Premiums, Investments | $0 | $25M | $29.3M | $15.7M | $11.1M | $9.8M | $8.7M | — |
| Gain (Loss) on Fair Value of Debt and Liability Instruments | $118.2M | — | — | $14.1M | -$2.3M | -$21M | -$24.4M | $0 |
| Gain (Loss) on Investments | $15.2M | $48.4M | -$21.3M | $12.9M | -$19.1M | $128.5M | $21.6M | — |
| Gain on sale of Telavant net assets | $110.4M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Gain on sale of subsidiary interests | $94.1M | $94.1M | $94.1M | $94.1M | — | — | — | $0 |
| Other Noncash Income (Expense) | -$5.6M | $17.9M | -$11.9M | -$4.2M | -$11.1M | -$6M | — | — |
| Other Non-cash Income and Expense | -$5.6M | $17.9M | -$11.9M | -$4.2M | -$11.1M | -$6M | — | — |
| Other Non-Cash Adjustments | -$5.6M | $17.9M | -$11.9M | -$4.2M | -$11.1M | -$6M | — | — |
| Other Non-Cash Income and Expense | -$5.6M | $17.9M | -$11.9M | -$4.2M | -$11.1M | -$6M | — | — |
| Accretion (Amortization) of Investment Discounts and Premiums | $0 | $25M | $29.3M | $15.7M | $11.1M | $9.8M | $8.7M | — |
| Change in Interest Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |